Dechra Pharmaceuticals
DPH.L
$46.11
Share price
-0.21%
Change (1 day)
3.48%
Change (1 year)
Categories
P/S ratio for Dechra Pharmaceuticals (DPH.L)
P/S ratio at the end of 2022: 5.50
According to Dechra Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.37236. At the end of 2022 the company had a P/S ratio of 5.50.
P/S ratio history for Dechra Pharmaceuticals from 2001 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 5.50 | -29.32% |
| 2021 | 7.78 | 30.33% |
| 2020 | 5.97 | 2.14% |
| 2019 | 5.84 | -15.6% |
| 2018 | 6.92 | 57.01% |
| 2017 | 4.41 | 0.41% |
| 2016 | 4.39 | 3.32% |
| 2015 | 4.25 | 29.63% |
| 2014 | 3.28 | 2.76% |
| 2013 | 3.19 | 225.33% |
| 2012 | 0.9806 | 17.05% |
| 2011 | 0.8378 | 21.62% |
| 2010 | 0.6889 | -12.94% |
| 2009 | 0.7913 | -12.11% |
| 2008 | 0.9003 | 24.93% |
| 2007 | 0.7206 | 34.45% |
| 2006 | 0.5360 | 4.44% |
| 2005 | 0.5132 | 25.81% |
| 2004 | 0.4079 | 63.98% |
| 2003 | 0.2488 | -31.48% |
| 2002 | 0.3630 | -36.11% |
| 2001 | 0.5683 |